A new anti-cancer immune therapy, Immunity Bio ANKTIVA

Nov '25 (edited) • 💡Research & Education

ImmunityBio 2025 Aug 26 press release, on finance.yahoo.com, https://finance.yahoo.com/news/initial-data-shows_100_disease-123000153.html, an intimal study is claimed to have demonstrated that 5 out of 5 patients with recurrent glioblastoma (glioblastoma growing after the standard protocol) demonstrated "100% disease control" (cancer volume not increasing) with 2 of the 5 "in near complete response". Glioblastoma is a difficult case, being inside the blood brain barrier. They indicate that is may prove to be effective on most or many cancer types.

1 comment